Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE40.6500
- TODAY'S CHANGE (%)-2.0800 (-4.8678%)
- Bid / Lots39.3300/ 1
- Ask / Lots42.1500/ 1
- Open / Previous Close42.3200 / 42.7300
- Day Range
- 52 Week Range
- Volume595,929
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 586 | 42.01 |
| 09:41 ET | 1250 | 42.25 |
| 09:43 ET | 250 | 42.268 |
| 09:48 ET | 400 | 42.13 |
| 09:50 ET | 1187 | 42.3 |
| 09:54 ET | 100 | 42.4 |
| 09:57 ET | 100 | 42.36 |
| 10:03 ET | 300 | 42.43 |
| 10:08 ET | 921 | 42.605 |
| 10:10 ET | 200 | 42.62 |
| 10:12 ET | 200 | 42.69 |
| 10:14 ET | 1000 | 42.605 |
| 10:17 ET | 394 | 42.7 |
| 10:19 ET | 200 | 42.61 |
| 10:21 ET | 700 | 42.55 |
| 10:24 ET | 900 | 42.64 |
| 10:26 ET | 200 | 42.635 |
| 10:28 ET | 500 | 42.635 |
| 10:30 ET | 3264 | 42.41 |
| 10:32 ET | 1018 | 42.33 |
| 10:33 ET | 200 | 42.33 |
| 10:35 ET | 1398 | 42.35 |
| 10:37 ET | 1954 | 42.14 |
| 10:39 ET | 200 | 42.135 |
| 10:42 ET | 840 | 42.185 |
| 10:44 ET | 100 | 42.185 |
| 10:46 ET | 100 | 42.185 |
| 10:48 ET | 100 | 42.185 |
| 10:50 ET | 1367 | 42.215 |
| 10:51 ET | 2000 | 42.08 |
| 10:53 ET | 100 | 42.07 |
| 10:55 ET | 200 | 42.02 |
| 10:57 ET | 700 | 42.07 |
| 11:00 ET | 300 | 42.05 |
| 11:02 ET | 250 | 42.05 |
| 11:04 ET | 900 | 42.15 |
| 11:06 ET | 100 | 42.175 |
| 11:08 ET | 600 | 42.17 |
| 11:09 ET | 200 | 42.195 |
| 11:11 ET | 600 | 42.13 |
| 11:13 ET | 400 | 42.1 |
| 11:18 ET | 100 | 42.135 |
| 11:22 ET | 804 | 42.135 |
| 11:24 ET | 1336 | 42.115 |
| 11:26 ET | 1225 | 42.12 |
| 11:27 ET | 4497 | 41.88 |
| 11:29 ET | 1100 | 41.85 |
| 11:31 ET | 534 | 41.76 |
| 11:33 ET | 2509 | 41.87 |
| 11:36 ET | 950 | 41.915 |
| 11:38 ET | 100 | 41.93 |
| 11:40 ET | 100 | 41.93 |
| 11:42 ET | 200 | 41.92 |
| 11:44 ET | 200 | 41.945 |
| 11:45 ET | 400 | 41.945 |
| 11:47 ET | 1467 | 41.94 |
| 11:49 ET | 700 | 42.01 |
| 11:51 ET | 1000 | 42.01 |
| 11:54 ET | 700 | 42.055 |
| 11:56 ET | 100 | 42.025 |
| 11:58 ET | 300 | 42.075 |
| 12:00 ET | 100 | 42.05 |
| 12:02 ET | 500 | 42.035 |
| 12:03 ET | 300 | 42.035 |
| 12:05 ET | 100 | 42.035 |
| 12:07 ET | 200 | 42.035 |
| 12:09 ET | 636 | 42.08 |
| 12:12 ET | 200 | 42.055 |
| 12:14 ET | 334 | 42.05 |
| 12:16 ET | 200 | 42.05 |
| 12:18 ET | 100 | 42.05 |
| 12:20 ET | 300 | 42.01 |
| 12:21 ET | 2000 | 42.3 |
| 12:23 ET | 100 | 42.335 |
| 12:25 ET | 300 | 42.315 |
| 12:27 ET | 100 | 42.315 |
| 12:30 ET | 800 | 42.39 |
| 12:32 ET | 3074 | 42.09 |
| 12:34 ET | 846 | 42.01 |
| 12:36 ET | 777 | 42.05 |
| 12:38 ET | 300 | 42.06 |
| 12:39 ET | 836 | 42.07 |
| 12:43 ET | 656 | 42 |
| 12:45 ET | 841 | 42.11 |
| 12:50 ET | 900 | 42 |
| 12:52 ET | 100 | 42.01 |
| 12:54 ET | 564 | 42 |
| 12:56 ET | 1534 | 42.02 |
| 12:57 ET | 200 | 42.03 |
| 12:59 ET | 200 | 42.03 |
| 01:03 ET | 500 | 42.1 |
| 01:06 ET | 1184 | 42.03 |
| 01:08 ET | 200 | 42.07 |
| 01:10 ET | 300 | 42.14 |
| 01:15 ET | 200 | 42.115 |
| 01:17 ET | 874 | 42.0565 |
| 01:19 ET | 300 | 42.115 |
| 01:24 ET | 300 | 42.115 |
| 01:26 ET | 100 | 42.11 |
| 01:28 ET | 2124 | 42.2 |
| 01:30 ET | 300 | 42.27 |
| 01:32 ET | 400 | 42.225 |
| 01:33 ET | 400 | 42.21 |
| 01:35 ET | 300 | 42.21 |
| 01:39 ET | 200 | 42.21 |
| 01:42 ET | 500 | 42.165 |
| 01:44 ET | 200 | 42.165 |
| 01:46 ET | 300 | 42.135 |
| 01:48 ET | 1096 | 42.12 |
| 01:50 ET | 10432 | 41.975 |
| 01:51 ET | 2602 | 41.98 |
| 01:53 ET | 37482 | 42.005 |
| 01:55 ET | 108223 | 41.88 |
| 01:57 ET | 1000 | 41.7 |
| 02:00 ET | 21386 | 41.6225 |
| 02:02 ET | 300 | 41.67 |
| 02:04 ET | 53481 | 41.48 |
| 02:06 ET | 6179 | 41.26 |
| 02:08 ET | 900 | 41.32 |
| 02:09 ET | 1004 | 41.52 |
| 02:11 ET | 3400 | 41.5 |
| 02:15 ET | 700 | 41.465 |
| 02:18 ET | 200 | 41.465 |
| 02:20 ET | 2284 | 41.405 |
| 02:22 ET | 3000 | 41.355 |
| 02:24 ET | 820 | 41.26 |
| 02:26 ET | 200 | 41.28 |
| 02:27 ET | 2739 | 41.255 |
| 02:29 ET | 700 | 41.155 |
| 02:31 ET | 1604 | 41.01 |
| 02:33 ET | 1318 | 41.24 |
| 02:36 ET | 200 | 41.26 |
| 02:38 ET | 208 | 41.26 |
| 02:40 ET | 300 | 41.32 |
| 02:42 ET | 600 | 41.265 |
| 02:44 ET | 528 | 41.34 |
| 02:45 ET | 100 | 41.38 |
| 02:47 ET | 1700 | 41.3 |
| 02:49 ET | 200 | 41.33 |
| 02:51 ET | 800 | 41.275 |
| 02:54 ET | 100 | 41.25 |
| 02:56 ET | 1100 | 41.31 |
| 02:58 ET | 1015 | 41.32 |
| 03:00 ET | 400 | 41.35 |
| 03:02 ET | 300 | 41.345 |
| 03:03 ET | 200 | 41.34 |
| 03:05 ET | 908 | 41.37 |
| 03:07 ET | 720 | 41.32 |
| 03:09 ET | 800 | 41.32 |
| 03:12 ET | 1237 | 41.305 |
| 03:14 ET | 2900 | 41.41 |
| 03:16 ET | 5208 | 41.245 |
| 03:18 ET | 1000 | 41.13 |
| 03:21 ET | 2300 | 41.19 |
| 03:23 ET | 1273 | 41.15 |
| 03:25 ET | 1800 | 41.21 |
| 03:27 ET | 1842 | 41.195 |
| 03:30 ET | 1500 | 41.21 |
| 03:32 ET | 900 | 41.14 |
| 03:34 ET | 1100 | 41.081 |
| 03:36 ET | 2571 | 41.006 |
| 03:38 ET | 800 | 41 |
| 03:39 ET | 1823 | 40.95 |
| 03:41 ET | 2023 | 41.13 |
| 03:43 ET | 1000 | 41.145 |
| 03:45 ET | 2143 | 41.125 |
| 03:48 ET | 2634 | 41.08 |
| 03:50 ET | 2987 | 41.24 |
| 03:52 ET | 2303 | 41.18 |
| 03:54 ET | 7521 | 41.065 |
| 03:56 ET | 17293 | 40.97 |
| 03:57 ET | 10934 | 40.79 |
| 03:59 ET | 55245 | 40.65 |
Apr 16, 2024
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting, from 8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 12, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham, from 7:13AM ET on Friday Apr 12, 2024 by Dow Jones
7:13AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:57AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:57AM ET on Wednesday Apr 10, 2024 by Dow JonesXenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, from 8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 4, 2024
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference, from 4:01PM ET on Thursday Apr 04, 2024 by Dow Jones
4:01PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.2B | -14.9x | --- |
Iovance Biotherapeutics Inc | 3.4B | -6.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
SpringWorks Therapeutics Inc | 3.4B | -9.1x | --- |
Crinetics Pharmaceuticals Inc | 3.5B | -11.9x | --- |
Biohaven Ltd | 3.5B | -6.8x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.18 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
